Ursprung des Netzwerks ersten Grades von Barbara Brunnhuber
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Mireca Medicines GmbH
Mireca Medicines GmbH Pharmaceuticals: MajorHealth Technology Mireca Medicines GmbH develops treatment for hereditary eye disease. The company was founded by François Paquet-Durand, Pieter Jaap Gaillard and Barbara Brunnhuber in 2017 and is headquartered in Tubingen,
4
| Holding Company | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Barbara Brunnhuber
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of Leiden | College/University | Doctorate Degree Doctorate Degree | |
University of Utrecht | College/University | Graduate Degree | |
ALZECURE PHARMA AB | Biotechnology | Director/Board Member | |
Valneva Sweden AB
Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | Biotechnology | Chief Executive Officer | |
Hoogstraate Consulting AB. | Chief Executive Officer | ||
The Dutch Chamber of Commerce In Sweden | Director/Board Member | ||
Hult International Business School | College/University | Masters Business Admin | |
NorthX Biologics Matfors AB
NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Biotechnology | Chief Executive Officer | |
Stockholm Brain Institute | Chairman | ||
Apotek Produktion & Laboratorier AB
Apotek Produktion & Laboratorier AB Pharmaceuticals: MajorHealth Technology Apotek Produktion & Laboratorier AB develops and manufactures pharmaceutical products. Its services include analytical services, clinical trials and contract manufacturing. The company is headquartered in Kungens Kurva, Sweden. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Schweden | 8 |
Niederlande | 4 |
Vereinigte Arabische Emirate | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 4 |
Operativ
Director/Board Member | 6 |
Founder | 3 |
Chief Executive Officer | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Barbara Brunnhuber
- Unternehmensverbindungen